SHENK, KEVIN D.,PARLATI, FRANCESCO,ZHOU, HAN-JIE,SYLVAIN, CATHERINE,SMYTH, MARK S.,BENNETT, MARK K.,LAIDIG, GUY J.
申请号：
CA2657213
公开号：
CA2657213C
申请日:
2007.06.19
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
